UROGEN PHARMA LTD URGN

US Healthcare Pharmaceutical Preparations
$38.02
+0.2%
52w: $12.96 – $38.02

Latest 13F among current holders filed 32 days ago (Jun 3, 2026)

Price — last 12 months

research preview data
12.9625.4938.02
Jun 20, 2025 Jul 2, 2026
Institutional holders
173
+5 QoQ
13F value
$834.8M
-18.5% QoQ
Smart-money holders
26
signal tier ≥ 2
New smart buyers
4
Q1 2026
Options barometer
1.1×
$4.3M calls / $3.8M puts

Institutional value by quarter

$422.2M
Q1 2024
$641.7M
Q2 2024
$446.6M
Q3 2024
$386.3M
Q4 2024
$460.7M
Q1 2025
$557.0M
Q2 2025
$887.9M
Q3 2025
$1.02B
Q4 2025
$834.8M
Q1 2026

Number of holders

113
Q1 2024
116
Q2 2024
129
Q3 2024
139
Q4 2024
141
Q1 2025
151
Q2 2025
161
Q3 2025
168
Q4 2025
173
Q1 2026

Who owns URGN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
RTW INVESTMENTS, LP ★2Fundamental diversified4.5M$81.7M0.8%Held
BlackRock, Inc. Index provider2.8M$51.2M0.0%+9.4%
TORONTO DOMINION BANK Bank broker2.6M$47.0M0.1%New
MORGAN STANLEY Bank broker2.6M$46.0M0.0%-0.1%
Kynam Capital Management, LP ★3Fundamental concentrated2.2M$40.4M2.6%New
Jefferies Financial Group Inc. Diversified mechanical2.2M$39.5M0.5%Held
Paradigm Biocapital Advisors LP ★2Fundamental concentrated1.7M$30.6M0.6%-61.9%
ACORN CAPITAL ADVISORS, LLC ★3Fundamental concentrated1.7M$30.1M8.6%+15.5%
SG Americas Securities, LLC Diversified mechanical1.7M$29.8M0.0%+20.3%
AMERICAN CENTURY COMPANIES INC Diversified mechanical1.6M$29.4M0.0%+20.5%
SILVERARC CAPITAL MANAGEMENT, LLC ★2Fundamental diversified1.5M$27.0M3.2%-13.6%
Opaleye Management Inc. ★2Fundamental concentrated1.4M$25.7M3.4%+432.7%
FRONTIER CAPITAL MANAGEMENT CO LLC Other1.3M$23.6M0.2%+68.1%
MENORA MIVTACHIM HOLDINGS LTD. ★2Fundamental diversified1.2M$20.7M0.1%Held
D. E. Shaw & Co., Inc. Quant stat arb1.0M$18.4M0.0%+6.3%
MPM BIOIMPACT LLC ★2Fundamental concentrated943.8K$17.0M1.3%+0.3%
J. Goldman & Co LP Quant stat arb938.9K$16.9M0.8%+82.9%
ORBIMED ADVISORS LLC ★2Fundamental diversified875.5K$15.7M0.4%Held
STATE STREET CORP Index provider874.2K$15.7M0.0%+8.3%
Migdal Insurance & Financial Holdings Ltd. Other770.9K$13.9M0.1%Held
Soleus Capital Management, L.P. ★2Fundamental diversified727.0K$13.1M0.5%+384.7%
GOLDMAN SACHS GROUP INC Bank broker598.5K$10.8M0.0%+30.2%
GEODE CAPITAL MANAGEMENT, LLC Index provider523.8K$9.4M0.0%+10.2%
Woodline Partners LP Other500.7K$9.0M0.0%Held
Boxer Capital Management, LLC ★2Fundamental concentrated500.0K$9.0M1.2%Held
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical409.6K$7.4M0.0%
TCG Crossover Management, LLC ★3Fundamental concentrated405.4K$7.3M0.2%-43.5%
ADAR1 Capital Management, LLC Other395.5K$7.1M0.4%+215.4%
SUPERSTRING CAPITAL MANAGEMENT LP ★2Fundamental concentrated387.4K$7.0M5.0%-46.1%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND Diversified mechanical387.1K$7.0M0.0%-65.6%
MILLENNIUM MANAGEMENT LLC Multistrat pod370.9K$6.7M0.0%-40.1%
TANG CAPITAL MANAGEMENT LLC ★2Fundamental diversified350.0K$6.3M0.3%Held
RICE HALL JAMES & ASSOCIATES, LLC Other285.8K$5.1M0.3%+1.4%
NORTHERN TRUST CORP Index provider275.9K$5.0M0.0%+16.2%
Parkman Healthcare Partners LLC Other275.0K$4.9M0.5%+62.9%
CITADEL ADVISORS LLC Multistrat pod268.0K$4.8M0.0%-63.7%
Privium Fund Management B.V. ★2Fundamental diversified238.1K$4.3M0.9%+10.9%
DEUTSCHE BANK AG\ Bank broker236.2K$4.2M0.0%-35.6%
VOLORIDGE INVESTMENT MANAGEMENT, LLC Diversified mechanical230.6K$4.1M0.0%-47.0%
Elmind Capital, LP ★3Fundamental concentrated220.0K$4.0M1.1%+120.0%
Ally Bridge Group (NY) LLC ★2Fundamental concentrated202.1K$3.6M3.6%New
Hennion & Walsh Asset Management, Inc. Other183.5K$3.3M0.1%+13.3%
TWO SIGMA INVESTMENTS, LP Quant stat arb177.9K$3.2M0.0%-26.2%
UBS Group AG Bank broker159.7K$2.9M0.0%-32.1%
Schonfeld Strategic Advisors LLC Multistrat pod158.1K$2.8M0.0%New
Atom Investors LP Quant stat arb145.3K$2.6M0.2%-38.0%
FMR LLC Long only active145.0K$2.6M0.0%+17.3%
AQR CAPITAL MANAGEMENT LLC Quant stat arb144.1K$2.6M0.0%-6.1%
Vestal Point Capital, LP ★2Fundamental diversified139.1K$2.5M0.1%New
BANK OF AMERICA CORP /DE/ Bank broker126.8K$2.3M0.0%-1.4%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.